Prognostic Effect Of Convertional Treatment In Pediatric Dilated Cardiomyopathy


Abstract views: 46 / PDF downloads: 61

Authors

  • Osman Başpınar Gaziantep University School Of Medicine Department Of Pediatrics
  • Metin Kılınç Gaziantep University School Of Medicine Department Of Pediatrics
  • Erkan Altuncu Gaziantep University School Of Medicine Department Of Pediatrics
  • Mesut Parlak Gaziantep University School Of Medicine Department Of Pediatrics
  • Yavuz Coşkun Gaziantep University School Of Medicine Department Of Pediatrics

DOI:

https://doi.org/10.58600/eurjther.2009-15-1-1240-arch

Keywords:

Dilated cardiomyopathy, Prognosis, Childhood

Abstract

The purpose of this study was to review our experience with conventional treated pediatric dilated caridomyopathy patients in our region and attempt to discover prognostic factors. We analyzed retrospectively the outcome of 41 patients during last six years. The patients were 23 girls, and 18 boys, ejection fraction 31.6±7.8%, follow-up period 14.07±14.2 months. Eight patients (19.5%) had died, 17 (41.4%) had recovery of systolic function. When analyzed from regained normal systolic function (17 patients) and others, first ejection fraction was not statistically significant (p=0.743). When separated from patient presentation age, 58.5% were smaller than two years. Sixth patients (25%) were died in smaller and two (11.7%) in bigger. Comparison between groups were not statistically differences (p=0.632 for deaths, p=0.594 for ejection fraction). We concluded that age; degrees of systolic functions were not differentiated favorable outcomes.

Metrics

Metrics Loading ...

References

Grenier MA, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000;139:86-95.

Towbin JA. Pediatric myocardial disease. Pediatr Clin North Am. 1999;46:289-312.

Schwartz ML, Cox GF, Lin AE, Korson MS, Perez-Atayde A, Lacro RV, et al. Clinical approach to genetic cardiomyopathy in children. Circulation. 1996;94:2021- 2038.

Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore), 1999;78:270-283.

Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics. 1998;101:369-376.

Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J. 1994;72:246-250.

Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639-1646.

Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647-1655.

Venugopalan P, Agarwal AK, Akinbami FO, El Nour IB, Subramanyan R. Improved prognosis of heart failure due to idiopathic dilated cardiomyopathy in children. Int J Cardiol. 1998;65:125–128.

Redfield MM, Gersh BJ, Bailey KR, Ballard DJ, Rodeheffer RJ. Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol. 1993;22:1921-1926.

Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, et al. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J. 1988;116:1455-1463.

Lewis AB. Prognostic value of echocardiography in children with idiopathic dilated cardiomyopathy. Am Heart J. 1994;128:133-136.

McMahon CJ, Nagueh SF, Eapen RS, Drewer WJ, Finkelshtyn I, Cao X, et al. Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study. Heart. 2004;90:908-915.

Matitiau A, Perez-Atayde A, Sanders SP, Sluymans S, Parness IA, Spevak PJ, et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994;90:1310-1318.

Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365- 369.

Tsirka AE, Trinkaus K, Chen SC, Lipshultz SE, Towbin JA, Colan SD, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004;44:391-397.

Cicoira M, Zanolla L, Latina L, Rossi A, Golia G, Briqhetti G, et al. Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with ‘classical' clinical diagnosis of idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2001;3:323-330.

Strauss A, Lock JE. Pediatric cardiomyopathy-a long way to go. N Engl J Med. 2003;348:1703-1705.

Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002;298:2188-2190.

Downloads

Published

2009-01-01

How to Cite

Başpınar, O., Kılınç, M., Altuncu, E., Parlak, M., & Coşkun, Y. (2009). Prognostic Effect Of Convertional Treatment In Pediatric Dilated Cardiomyopathy. European Journal of Therapeutics, 15(1), 5–9. https://doi.org/10.58600/eurjther.2009-15-1-1240-arch

Issue

Section

Clinical Research